| abstract |
NOVEL COMPOUNDS II 5 The invention provides compounds of formula R 14 W N N X-R 5 (1) wherein R , R3, R4, R , R , X and W are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof, 10 together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of human neutrophil elastase. |